SYNVISC-ONE (Hylan G-F 20) - Synovial fluid supplementation substance
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
23-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Sanofi-Aventis Australia Pty Ltd
Class:
Class III
Manufactured by:
Genzyme Corporation 1125 Pleasant View Terrace, Ridgefield, NJ, 07657 United States Of America
Therapeutic area:
44757 - Synovial fluid supplementation substance
Therapeutic indications:
A sterile, nonpyrogenic, elastoviscous fluid containing hylan polycaccharide (Hylan polymer 8.0 mg/mL) hydrated in physiological saline. Synvisc-One is only intended for intra-articular use to treat pain associated with osteoarthritis of the knee.
Authorization status:
A
Authorization date:
2009-02-09
